212 related articles for article (PubMed ID: 32668257)
41. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation.
Burgdorf S; Schölz C; Kautz A; Tampé R; Kurts C
Nat Immunol; 2008 May; 9(5):558-66. PubMed ID: 18376402
[TBL] [Abstract][Full Text] [Related]
42. Absence of scavenger receptor A promotes dendritic cell-mediated cross-presentation of cell-associated antigen and antitumor immune response.
Guo C; Yi H; Yu X; Hu F; Zuo D; Subjeck JR; Wang XY
Immunol Cell Biol; 2012 Jan; 90(1):101-8. PubMed ID: 21383767
[TBL] [Abstract][Full Text] [Related]
43. Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol.
Polanco JC; Hand GR; Briner A; Li C; Götz J
Acta Neuropathol; 2021 Feb; 141(2):235-256. PubMed ID: 33417012
[TBL] [Abstract][Full Text] [Related]
44. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells.
Liu X; Lu L; Yang Z; Palaniyandi S; Zeng R; Gao LY; Mosser DM; Roopenian DC; Zhu X
J Immunol; 2011 Apr; 186(8):4674-86. PubMed ID: 21402891
[TBL] [Abstract][Full Text] [Related]
45. The role of MHC class I recycling and Arf6 in cross-presentation by murine dendritic cells.
Montealegre S; Abramova A; Manceau V; de Kanter AF; van Endert P
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31740564
[TBL] [Abstract][Full Text] [Related]
46. Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells.
Dong H; Wen ZF; Chen L; Zhou N; Liu H; Dong S; Hu HM; Mou Y
Int J Nanomedicine; 2018; 13():3353-3365. PubMed ID: 29922056
[TBL] [Abstract][Full Text] [Related]
47. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
Montealegre S; van Endert PM
Front Immunol; 2018; 9():3098. PubMed ID: 30666258
[TBL] [Abstract][Full Text] [Related]
48. Efficient cross-presentation of soluble exogenous antigens introduced into dendritic cells using a weak-based amphiphilic peptide.
Ikeuchi N; Futami J; Hosoi A; Noji S; Kurachi M; Ueha S; Fujii S; Yamada H; Matsushima K; Moriyasu F; Kakimi K
Biochem Biophys Res Commun; 2010 Feb; 392(2):217-22. PubMed ID: 20067764
[TBL] [Abstract][Full Text] [Related]
49. Innate Immune Signals Induce Anterograde Endosome Transport Promoting MHC Class I Cross-Presentation.
Weimershaus M; Mauvais FX; Saveanu L; Adiko C; Babdor J; Abramova A; Montealegre S; Lawand M; Evnouchidou I; Huber KJ; Chadt A; Zwick M; Vargas P; Dussiot M; Lennon-Dumenil AM; Brocker T; Al-Hasani H; van Endert P
Cell Rep; 2018 Sep; 24(13):3568-3581. PubMed ID: 30257216
[TBL] [Abstract][Full Text] [Related]
50. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation.
Cohn L; Chatterjee B; Esselborn F; Smed-Sörensen A; Nakamura N; Chalouni C; Lee BC; Vandlen R; Keler T; Lauer P; Brockstedt D; Mellman I; Delamarre L
J Exp Med; 2013 May; 210(5):1049-63. PubMed ID: 23569326
[TBL] [Abstract][Full Text] [Related]
51. If it ain't broke, break it: facilitating antigen cross-presentation.
Rodríguez-Silvestre P; Kozik P
Trends Mol Med; 2022 Apr; 28(4):251-252. PubMed ID: 35288004
[TBL] [Abstract][Full Text] [Related]
52. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
Udono H; Ichiyanagi T; Mizukami S; Imai T
Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
[TBL] [Abstract][Full Text] [Related]
53. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.
Sánchez-Paulete AR; Teijeira A; Cueto FJ; Garasa S; Pérez-Gracia JL; Sánchez-Arráez A; Sancho D; Melero I
Ann Oncol; 2017 Dec; 28(suppl_12):xii44-xii55. PubMed ID: 28945841
[TBL] [Abstract][Full Text] [Related]
54. Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.
Juliano RL
Nucleic Acid Ther; 2018 Jun; 28(3):166-177. PubMed ID: 29708838
[TBL] [Abstract][Full Text] [Related]
55. Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation.
Tacken PJ; Ginter W; Berod L; Cruz LJ; Joosten B; Sparwasser T; Figdor CG; Cambi A
Blood; 2011 Oct; 118(15):4111-9. PubMed ID: 21860028
[TBL] [Abstract][Full Text] [Related]
56. Rab22a controls MHC-I intracellular trafficking and antigen cross-presentation by dendritic cells.
Cebrian I; Croce C; Guerrero NA; Blanchard N; Mayorga LS
EMBO Rep; 2016 Dec; 17(12):1753-1765. PubMed ID: 27861124
[TBL] [Abstract][Full Text] [Related]
57. Lipid peroxidation causes endosomal antigen release for cross-presentation.
Dingjan I; Verboogen DR; Paardekooper LM; Revelo NH; Sittig SP; Visser LJ; Mollard GF; Henriet SS; Figdor CG; Ter Beest M; van den Bogaart G
Sci Rep; 2016 Feb; 6():22064. PubMed ID: 26907999
[TBL] [Abstract][Full Text] [Related]
58. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
Fu C; Jiang A
Front Immunol; 2018; 9():3059. PubMed ID: 30619378
[TBL] [Abstract][Full Text] [Related]
59. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
[TBL] [Abstract][Full Text] [Related]
60. Prolonged antigen survival and cytosolic export in cross-presenting human gammadelta T cells.
Meuter S; Eberl M; Moser B
Proc Natl Acad Sci U S A; 2010 May; 107(19):8730-5. PubMed ID: 20413723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
